FG
Fairman Group Portfolio holdings
AUM
$127M
Turnover
8.16%
1-Year Est. Return
6.28%
This Fund
S&P 500
This Quarter
Est. Return
-6.04%
1 Year Est. Return
+6.28%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.4M
AUM Growth
-$7.47M
(-7.1%)
Cap. Flow
+$4.49M
Cap. Flow
% of AUM
4.56%
Top 10 Holdings %
Top 10 Hldgs %
67.87%
Holding
414
New
16
Increased
56
Reduced
19
Closed
11
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$567K |
| 2 |
Eaton Vance Enhance Equity Income Fund II
EOS
|
+$543K |
| 3 |
Calamos Strategic Total Return Fund
CSQ
|
+$536K |
| 4 |
Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG
|
+$516K |
| 5 |
Global X NASDAQ-100 Covered Call ETF
QYLD
|
+$471K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quaker Houghton
KWR
|
+$226K |
| 2 |
NVIDIA
NVDA
|
+$202K |
| 3 |
Arch Capital
ACGL
|
+$134K |
| 4 |
ExxonMobil
XOM
|
+$115K |
| 5 |
Inspire Small/Mid Cap Impact ETF
ISMD
|
+$73.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.54% |
| 2 | Technology | 28.94% |
| 3 | Financials | 12.75% |
| 4 | Industrials | 5.24% |
| 5 | Healthcare | 2.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Viatris
VTRS
$20.1B
| $3.23K | ﹤0.01% |
304
| – | – |
2023 Q4
2 quarters
|
|
227
Markel Group
MKL
$22.2B
| $3.15K | ﹤0.01% |
2
| – | – |
2023 Q4
2 quarters
|
|
228
Barrick Mining
B
$63.9B
| $3.1K | ﹤0.01% |
186
| – | – |
2023 Q4
2 quarters
|
|
229
Tyler Technologies
TYL
$14.3B
| $3.02K | ﹤0.01% |
6
| – | – |
2023 Q4
2 quarters
|
|
230
Fidelity National Information Services
FIS
$18.3B
| $3.01K | ﹤0.01% |
40
| – | – |
2023 Q4
2 quarters
|
|
231
Novanta
NOVT
$5.31B
| $2.94K | ﹤0.01% |
18
| – | – |
2023 Q4
2 quarters
|
|
232
Johnson Controls International
JCI
$92.2B
| $2.87K | ﹤0.01% |
43
| – | – |
2023 Q4
2 quarters
|
|
233
Simpson Manufacturing
SSD
$7.02B
| $2.87K | ﹤0.01% |
17
| – | – |
2023 Q4
2 quarters
|
|
234
Medtronic
MDT
$121B
| $2.86K | ﹤0.01% |
36
| – | – |
2023 Q4
2 quarters
|
|
235
Lennar Class A
LEN
$17.5B
| $2.85K | ﹤0.01% |
20
| – | – |
2023 Q4
2 quarters
|
|
236
Air Products & Chemicals
APD
$65.1B
| $2.84K | ﹤0.01% |
11
| – | – |
2023 Q4
2 quarters
|
|
237
Canadian National Railway
CNI
$72.5B
| $2.83K | ﹤0.01% |
24
| – | – |
2023 Q4
2 quarters
|
|
238
NextEra Energy
NEE
$164B
| $2.83K | ﹤0.01% |
40
| – | – |
2023 Q4
2 quarters
|
|
239
Roper Technologies
ROP
$36.8B
| $2.82K | ﹤0.01% |
5
| – | – |
2023 Q4
2 quarters
|
|
240
iShares Russell 1000 Value ETF
IWD
$83B
| $2.79K | ﹤0.01% |
16
| – | – |
2023 Q4
2 quarters
|
|
241
Qualcomm
QCOM
$185B
| $2.79K | ﹤0.01% |
14
| – | – |
2023 Q4
2 quarters
|
|
242
Marsh
MRSH
$85.3B
| $2.74K | ﹤0.01% |
13
| – | – |
2023 Q4
2 quarters
|
|
243
Mondelez International
MDLZ
$79.8B
| $2.7K | ﹤0.01% |
41
| – | – |
2023 Q4
2 quarters
|
|
244
Brown & Brown
BRO
$21.7B
| $2.59K | ﹤0.01% |
29
| – | – |
2023 Q4
2 quarters
|
|
245
HealthEquity
HQY
$7.44B
| $2.59K | ﹤0.01% |
30
| – | – |
2023 Q4
2 quarters
|
|
246
Prime Medicine
PRME
$566M
| $2.57K | ﹤0.01% |
500
| – | – |
2023 Q4
2 quarters
|
|
247
International Flavors & Fragrances
IFF
$22.8B
| $2.49K | ﹤0.01% |
26
| – | – |
2023 Q4
2 quarters
|
|
248
Autodesk
ADSK
$48.1B
| $2.48K | ﹤0.01% |
10
| – | – |
2023 Q4
2 quarters
|
|
249
Trinity Industries
TRN
$2.08B
| $2.39K | ﹤0.01% |
80
| – | – |
2023 Q4
2 quarters
|
|
250
Lockheed Martin
LMT
$120B
| $2.34K | ﹤0.01% |
5
| – | – |
2023 Q4
2 quarters
|
|
Similar funds
APMC
DIG
RWIA
AWS
CPX
KCM
EHAM
FC
Fairman Group's Q2 2024 Portfolio in Review
As of Q2 2024, Fairman Group held 414 positions worth $98.4M, down 7.1% from $106M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Fairman Group deployed $4.49M of net new capital in Q2 2024, opening 16 new positions and adding to 56 existing holdings. Its largest new stake was Eaton Vance Enhance Equity Income Fund II: 26,418 shares worth $575K.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 37% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Quaker Houghton, an estimated $226K trimmed.
- Fairman Group's largest Q2 2024 buy was Eaton Vance Enhance Equity Income Fund II: 26,418 shares worth $575K.
- Fairman Group added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $567K increase.
- Fairman Group's biggest Q2 2024 reduction was Quaker Houghton, cutting an estimated $226K.
- Fairman Group fully exited Boeing in Q2 2024, selling an estimated $46.7K.
- Fairman Group's ten largest holdings make up 68% of its $98.4M portfolio in Q2 2024.
- Fairman Group opened 16 new positions and closed 11 in Q2 2024.
- Fairman Group's portfolio value fell 7.1% quarter-over-quarter to $98.4M.
Based on Fairman Group's 13F filing for Q2 2024, filed 29 Jul 2024.